Table 1 Clinical data and clinical outcomes of the two groups
Group A | Group B | P value | |
|---|---|---|---|
No. of patients (n) | 70 | 40 | |
Male/female (n) | 21/49 | 16/24 | |
Mean age (years) | 76.13 ± 15.20 | 75.08 ± 17.60 | 0.612 |
Follow-up (months) | 60.50 ± 15.20 | 58.20 ± 17.60 | 0.650 |
BMD | −3.9 ± 0.8 | −4.0 ± 0.6 | 0.521 |
BMI | 23.2 ± 4.2 | 24.8 ± 3.3 | 0.801 |
Hospitalization time (days) | 3.2 ± 1.5 | 6.0 ± 2.5 | 0.0001 |
Surgery time (minutes) | 30.50 ± 10.50 | 70.70 ± 20.60 | 0.0001 |
Smoker/non-smoker | 9/61 | 5/35 | 0.411 |
With/without DM | 15/55 | 8/32 | 0.320 |
With/without hypertension | 35/35 | 18/22 | 0.895 |
With/without coronary disease | 11/59 | 7/33 | 0.305 |
Surgical haemorrhage (ml) | 10.80 ± 5.20 | 100.30 ± 30.50 | 0.0001 |
Cement volume (ml) | 5.09 ± 0.65 | 5.15 ± 0.35 | 0.765 |
VAS score | |||
before treatment | 6.5 ± 1.88 | 7.0 ± 1.35 | 0.554 |
final follow-up | 2.60 ± 0.55* | 1.01 ± 0.25* | 0.012 |
ODI score | |||
before treatment | 41.15 ± 5.02 | 40.98 ± 3.53 | 0.574 |
final follow-up | 40.75 ± 3.52 | 4.83 ± 1.15* | 0.0001 |